Functional deficits precede structural lesions in mice with high-fat diet-induced diabetic retinopathy

Diabetes

Volumn 65, Issue 4, 2016, Pages 1072-1084

  Rajagopal, Rithwick ^a   Bligard, Gregory W ^a   Zhang, Sheng ^a   Yin, Li ^a   Lukasiewicz, Peter ^a   Semenkovich, Clay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRYPSIN;

A WAVE; AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; BLOOD VESSEL PERMEABILITY; BODY COMPOSITION; CONTROLLED STUDY; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ENZYME INDUCTION; FEMALE; GLUCOSE INTOLERANCE; LATENT PERIOD; LIPID DIET; MALE; METABOLIC DISORDER; MICROANGIOPATHY; MOUSE; MOUSE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSCILLATORY POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; RETINA BLOOD VESSEL; RETINAL THICKNESS; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; COMPLICATION; DISEASE COURSE; EXPERIMENTAL DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA DISEASE; ULTRASTRUCTURE;

ANIMALS; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DIET, HIGH-FAT; DISEASE PROGRESSION; ELECTRORETINOGRAPHY; FEMALE; MALE; MICE; MICE, INBRED C57BL; RETINAL DISEASES; RETINAL VESSELS;

EID: 84962159246     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-1255     Document Type: Article

References (54)

1. World Health Organization. Prevention of Blindness and Visual Impairment. Global Data on Visual Impairments 2010 [article online]. Available from http://www.who.int/blindness/publications/globaldata/en/. Accessed 14 March 2014
2. Aiello LP, Avery RL, Arrigg P.G., et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-1487
3. Ferrara N, Damico L, Shams N., Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 2006; 26:859-870
4. Do DV, Nguyen QD, Khwaja A.A., et al.; READ-2 Study Group. Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatment. JAMA Ophthalmol 2013; 131:139-145
5. Kurihara T, Westenskow PD, Bravo S, Aguilar E., Friedlander M. Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 2012; 122: 4213-4217
6. Gillies MC, McAllister IL, Zhu M, et al Intravitreal triamcinolone prior to laser treatment of diabetic macular edema: 24-month results of a randomized controlled trial. Ophthalmology 2011; 118:866-872
7. Barber AJ, Antonetti DA, Kern T.S., et al. The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 2210-2218
8. Midena E, Segato T, Radin S., et al. Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 1989; 21:106-111
9. Babel J, Leuenberger P. A long term study on the ocular lesions in streptozotocin diabetic rats. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1974; 189: 191-209
10. Muller YD, Golshayan D, Ehirchiou D., et al. Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes 2011; 60:2331-2340
11. Perry DJ, Weiss RB Nephrotoxicity of streptozocin. Ann Intern Med 1982; 96:122
12. Kume E, Fujimura H, Matsuki N., et al. Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice. Exp Toxicol Pathol 2004; 55: 467-480
13. Kraska A, Santin MD, Dorieux O, et al In vivo cross-sectional characterization of cerebral alterations induced by intracerebroventricular administration of streptozotocin. PLoS One 2012; 7:e46196
14. Rai S, Kamat PK, Nath C, Shukla R. Glial activation and post-synaptic neurotoxicity: the key events in Streptozotocin (ICV) induced memory impairment in rats. Pharmacol Biochem Behav 2014; 117:104-117
15. Shoham S, Bejar C, Kovalev E., Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol 2003; 184:1043-1052
16. McLenachan S, Chen X, McMenamin P.G., Rakoczy EP. Absence of clinical correlates of diabetic retinopathy in the Ins2Akita retina. Clin Experiment Ophthalmol 2013; 41:582-592
17. Pires I, Santos AR, Nunes S, Lobo C. Macular thickness measured by stratus optical coherence tomography in patients with diabetes type 2 and mild nonproliferative retinopathy without clinical evidence of macular edema. Ophthalmologica 2013; 229:181-186
18. Zhao XF, Wan J, Powell C., Ramachandran R, Myers MG Jr, Goldman D. Leptin and IL-6 family cytokines synergize to stimulate Müller glia reprogramming and retina regeneration. Cell Reports 2014; 9:272-284
19. Towler DA, Bidder M, Latifi T., Coleman T, Semenkovich CF. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem 1998; 273:30427-30434
20. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004; 45:3330-3336
21. Elhabashy SA, Elbarbary NS, Nageb K.M., Mohammed MM. Can optical coherence tomography predict early retinal microvascular pathology in type 1 diabetic adolescents without minimal diabetic retinopathy? A single-centre study. J Pediatr Endocrinol Metab 2015; 28:139-146
22. Vujosevic S, Midena E. Retinal layers changes in human preclinical and early clinical diabetic retinopathy support early retinal neuronal and Müller cells alterations. J Diabetes Res 2013; 2013:905058
23. Robinson R, Barathi VA, Chaurasia S.S., Wong TY, Kern TS. Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals. Dis Model Mech 2012; 5:444-456
24. Xu Q, Qaum T, Adamis AP Sensitive blood-retinal barrier breakdown quantitation using Evans blue. Invest Ophthalmol Vis Sci 2001; 42:789-794
25. Bearse MA J.r., Adams AJ, Han Y, et al A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res 2006; 25: 425-448
26. Bresnick GH, Korth K, Groo A., Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol 1984; 102:1307-1311
27. Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh) 1980; 58:865-878
28. Yonemura D, Aoki T, Tsuzuki K. Electroretinogram in diabetic retinopathy. Arch Ophthalmol 1962; 68:19-24
29. Vandanmagsar B, Youm YH, Ravussin A, et al The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 2011; 17:179-188
30. Mohamed IN, Hafez SS, Fairaq A, Ergul A., Imig JD, El-Remessy AB. Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet. Diabetologia 2014; 57: 413-423
31. Zhou R, Tardivel A, Thorens B., Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140
32. Doyle SL, Campbell M, Ozaki E., et al. NLRP3 has a protective role in agerelated macular degeneration through the induction of IL-18 by drusen components. Nat Med 2012; 18:791-798
33. Tarallo V, Hirano Y, Gelfand B.D., et al. DICER1 loss and Alu RNA induce agerelated macular degeneration via the NLRP3 inflammasome and MyD88. Cell 2012; 149:847-859
34. Wong-Riley MT. Energy metabolism of the visual system. Eye Brain 2010; 2: 99-116
35. Sapieha P, Chen J, Stahl A., et al. Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice. Nutr Diabetes 2012; 2:e36
36. Hancock HA, Kraft TW Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004; 45:1002-1008
37. Kohzaki K, Vingrys AJ, Bui BV Early inner retinal dysfunction in streptozotocin-induced diabetic rats. Invest Ophthalmol Vis Sci 2008; 49: 3595-3604
38. Li Q, Zemel E, Miller B., Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 2002; 74:615-625
39. Mancini JE, Ortiz G, Croxatto J.O., Gallo JE. Retinal upregulation of inflammatory and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet. BMC Ophthalmol 2013; 13:14
40. Marçal A.C., Leonelli M, Fiamoncini J., et al. Diet-induced obesity impairs AKT signalling in the retina and causes retinal degeneration. Cell Biochem Funct 2013; 31:65-74
41. Noda K, Nakao S, Zandi S., Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J 2014; 28:2038-2046
42. Asi H, Perlman I. Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis. Doc Ophthalmol 1992; 79:125-139
43. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci 2004; 45:948-954
44. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci 1997; 38:2586-2596
45. Layton CJ, Safa R, Osborne NN Oscillatory potentials and the b-Wave: partial masking and interdependence in dark adaptation and diabetes in the rat. Graefes Arch Clin Exp Ophthalmol 2007; 245:1335-1345
46. Sims MH. Partial masking of the canine electroretinogram by oscillatory potentials. The problem of frequency bandwidth. J Vet Intern Med 1990; 4:40-42
47. Heynen H, Wachtmeister L, van Norren D. Origin of the oscillatory potentials in the primate retina. Vision Res 1985; 25:1365-1373
48. Wachtmeister L, Dowling JE The oscillatory potentials of the mudpuppy retina. Invest Ophthalmol Vis Sci 1978; 17:1176-1188
49. Attwell D, Buchan AM, Charpak S, Lauritzen M., Macvicar BA, Newman EA. Glial and neuronal control of brain blood flow. Nature 2010; 468:232-243
50. Cerani A, Tetreault N, Menard C., et al. Neuron-derived semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab 2013; 18:505-518
51. Mishra A, Newman EA Inhibition of inducible nitric oxide synthase reverses the loss of functional hyperemia in diabetic retinopathy. Glia 2010; 58:1996-2004
52. Okabe K, Kobayashi S, Yamada T., et al. Neurons limit angiogenesis by titrating VEGF in retina. Cell 2014; 159:584-596
53. Wen H, Gris D, Lei Y., et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 2011; 12:408-415
54. Moon JS, Lee S, Park M.A., et al. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis. J Clin Invest 2015; 125:665-680